Taflopres Ophthalmic Solution Eye Drop 0.0015%+0.5% is a Product of the Generic Tafluprost + Timolol

What Is Taflopres Ophthalmic Solution Eye Drop 0.0015%+0.5% Indications and Uses?

This ophthalmic solution is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Pharmacology (Source, Chemical and Physical Composition) Of Taflopres Ophthalmic Solution Eye Drop 0.0015%+0.5%

This is a combination of prostaglandin analog-Tafluprost and & beta-adrenergic receptor inhibitor, Timolol Maleate. Taflopres Ophthalmic Solution Eye Drop 0.0015%+0.5% (Tafluprost + Timolol) is prostaglandin analog which is a selective FP prostanoid receptor agonist is believed to reduce intraocular pressure by increasing uveoscleral outflow of aqueous humor. Timolol is a non-selective β-adrenergic receptor blocker. Exact mechanism of ocular hypotensive effect is unclear, but it is thought to be related to reduction of aqueous humor formation.

Dosage And Administration of Taflopres Ophthalmic Solution Eye Drop 0.0015%+0.5%

Instill one drop in the affected eye once daily in the evening.

Drug Interactions of Taflopres Ophthalmic Solution Eye Drop 0.0015%+0.5%

No interaction studies have been performed.

Side Effects of Taflopres Ophthalmic Solution Eye Drop 0.0015%+0.5%

The most frequently reported treatment-related adverse reaction is ocular hyperemia. Rare side effects observed include eye irritation and blurred vision.

Precautions And Warnings for Taflopres Ophthalmic Solution Eye Drop 0.0015%+0.5%

Pigmentation : Taflopres Ophthalmic Solution Eye Drop 0.0015%+0.5% (Tafluprost + Timolol) ophthalmic solution has been reported to cause changes to pigmented tissues. The most frequently reported changes have been increased pigmentation of the iris, periorbital tissue (eyelid) and eyelashes. Eyelash Changes : The Product may gradually change eyelashes and vellus hair in the treated eye. These changes include increased length, color, thickness, shape and number of lashes. Intraocular Inflammation: should be used with caution in patients with active intraocular inflammation (e.g., iritis/uveitis). Macular Edema : Macular edema & cystoid macular edema has been reported during treatment with prostaglandin F2α analogs.

Use During Pregnancy and Lactation

Pregnancy : Pregnancy Category C. There are no adequate and well-controlled studies in pregnant woman. The product should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus. Nursing Mothers : It is not known whether the drug or its metabolites are excreted in human milk. Caution should be exercised when product is administered to a nursing woman.

Therapeutic Class

Drugs for miotics and glaucoma

Storage Conditions of It

Store in a cool & dry place, protect from light. Keep out of the reach of children. preservative containing sterile eye drops : It is desirable that the contents should not be used more than 30 days after first opening. Preservative free sterile eye drops : Store unopened container at 2°C to 8°C (in a refrigerator). After opening, Do not store above 25°C. Store in dry place protected from light. Keep out of reach of children. Do not touch the dropper tip to any surface. It is desirable that the contents should not be used more than 60 days after first opening of the bottle. Protect from freezing. Pack Image: Taflopres 0.0015%+0.5% Eye Drop Thanks for using MedEx! How would you rate your experience so far?